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Insomnia and Mild
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K. Dickerson, FNP1, T. Kendall-Wilson, RN1,2,
A. Depelteau, PhD1, R. Copeland, MD1,
and K. Whalen, BA1

Abstract
Insomnia is a common problem in older people, especially in patients with mild cognitive impairment (MCI) whose
circadian rhythm is often compromised. Insomnia exerts such a toll on caregivers that it is frequently the primary
reason for seeking to institutionalize their loved ones. Three different types of insomnia are recognized: sleep-onset
or initial insomnia, sleep maintenance or middle insomnia, and early morning awakening or late insomnia. Nocturnal
hypoglycemia, as a cause of middle insomnia, is the main focus of this case study. Other types of insomnia are also
briefly reviewed. The management of insomnia is then discussed including sleep hygiene, the usefulness and potential
drawbacks of dietary supplements, nonprescription over-the-counter preparations and prescription hypnotics. Sleep
architecture is then briefly reviewed, emphasizing the importance of its integrity and the role of each sleep stage.
Keywords
Alzheimer’s/dementia, caregiving and management, cognition, confusional states, anxiety
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Objectives

died about a year ago, because she was unable to
take care of the large house she lived in. Her
daughter and son-in-law converted the den into a
room for her. Esther is physically independent,
drives her own car and is socially active. Apart
from the hypoglycemics, she is on no other medication. Her hearing is impaired; she wears hearing aids.
•• Miranda is Esther’s daughter.
•• Donald is Miranda’s husband.
•• Mary Lee is Miranda and Donald’s 4-year-old
daughter.

At the end of this case, presentation readers will:
1.

2.
3.
4.
5.

Recognize common causes of insomnia in older
patients with mild cognitive impairment, with
special emphasis on nocturnal hypoglycemia as
a cause of sleep maintenance insomnia or middle
insomnia.
Appreciate the nonpharmacological management of insomnia.
Know potential benefits and drawbacks of sleep
aids available over-the-counter.
Appreciate the usefulness, limitations, and
adverse effects of commonly used hypnotics.
Understand the importance of sleep architecture
and the main functions of each sleep stage.

Case Presentation
Characters
•• Esther, 72 years old, has mild cognitive impairment, diagnosed about 2 years ago. She also has
diabetes mellitus, well-controlled by oral hypoglycemics. She has been living with her daughter,
son-in-law, and granddaughter, since her husband

Scenario
It is close to 6:00 p.m. The family is sitting at the dining
room table. Esther is not hungry and does not eat.
Miranda asks her if she is going to eat. Esther replies she
is not really hungry, she’s been sitting all day reading
1
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and plans to exercise for at least an hour on the stationary bike before going to bed. She explains that she borrowed a 90-min documentary DVD on climate change
from the library and plans to watch it while exercising.
Donald asks her if she would like some of the cheesecake he bought. Esther again declines, excuses herself
and goes to exercise on the stationary bicycle.
After exercising for over an hour, Esther returns to
the front room where Miranda and Donald are watching
a TV movie. Mary Lee is sleeping in her own room.
Esther says that she plans to shower and then will head
straight for bed. She enjoyed her exercise session and
now feels physically tired but mentally relaxed and
ready for a good night sleep. “Isn’t it too early for bed?”
Donald asks. “It’s only about eight in the evening.”
Esther replies, “No, I’m ready for bed.”
Donald asks, “Aren’t you going to eat anything
before going to bed? What about the cheesecake I just
bought?” Esther replies, “No thanks. I’m so tired I’ll fall
asleep as soon as my head hits the pillow.” Donald persists, “Shall I prepare you a cup of herbal tea or hot
chocolate or how about some cookies?” Esther replies,
“No thanks. I’ll just shower and then go to straight to
bed.” Almost in unison Miranda and Donald say, “OK,
have a good night’s sleep.”
Miranda is somewhat concerned: “Do you think she
is depressed? She hardly touched her food and had nothing to eat since we had that cup of tea when you came
back from work.” Donald is not concerned. He only
hopes she has a good night’s sleep because he has a very
heavy day at work the following day and plans to leave
home at about 5:00 a.m. He says,
My main concern is that we have a repeat of last week
when she woke up at about 2:00 a.m., could not fall asleep
and tried to prepare breakfast. In the process she made so
much noise that she even woke up the neighbors.

On the way to their bedroom they notice that lights are
out in Esther’s room. “Keep your fingers crossed.”
Donald murmurs in Miranda’s ear as they head toward
their bedroom.
It is about 2:00 a.m. Everybody is sound asleep
except for Esther. She’s been awake for about 30 min.
She goes to the bathroom again, then returns to bed. She
cannot sleep. She tosses and turns and is wide-awake.
She tries to read but gives up. She looks for her hearing
aids but drops them on the floor and cannot reach them
because they rolled under her bed. She switches on the
TV but cannot hear so she increases the volume so high
that it wakes up Miranda and Donald. Very quickly, an
altercation develops between Miranda and Donald.
Tempers flare. Now Mary Lee is awake and crying.
Donald states that the time has come for Esther to be
placed in a nursing home or assisted living facility
because he needs a full night sleep: “This cannot continue! Your mother is jeopardizing my career and
destroying our marriage.”

Case Analysis
Turning Points/Triggers That Lead to This
Aberrant Behavior Include
No food/drink for a few hours before going to bed. Esther
did not have dinner and it is questionable how much she
ate earlier that day. Therefore, by 2:00 a.m. her blood
glucose levels would have been sufficiently low to stimulate the sympathetic nervous system and release of catecholamines (adrenaline and noradrenaline) which
would then wake her up and induce anxiety and irritability (Borbely, Mattmann, Loepfe, Strauch, & Lehmann,
1985). The catecholamine surge also may induce cardiac arrhythmias, which may reduce the stroke volume,
cardiac output, and subsequently cerebral blood flow
and perfusion thus worsening the patient’s cognitive
deficit. Nocturnal hypoglycemia is likely to occur in
Assisted Living Facilities and nursing homes when the
last substantial meal of the day can be served as early as
5:00 p.m. Even though snacks are usually available later
in the evening and night, residents may not eat them,
because they often do not feel hungry or have difficulties reaching the dining area.
Esther also has diabetes mellitus and is on oral hypoglycemics. As such, she is much more likely to develop
bouts of hypoglycemia. The impact of hypoglycemia is
significant in terms of sleep quality and next-day function (Brod, Wolden, Christensen, & Bushnell, 2013;
Evans et al., 2013; Harris et al., 2014), even among the
younger population with diabetes mellitus (Brod,
Christensen, & Bushnell, 2012; Fulcher et al., 2014;
Iscoe & Riddell, 2011; Jennum et al., 2015; Khunti et al.,
2016; Klimontov & Myakina, 2017; Munshi et al., 2011;
Porcellati, Lin, Lucidi, Bolli, & Fanelli, 2017; Speight
et al., 2016; Yang, Kim, Baek, Kim, & Park, 2016).
Could it have been avoided? Esther should have been
encouraged to eat dinner regardless of whether she was
feeling hungry. This would have ensured that her plasma
glucose level does not drop to the extent of stimulating
the sympathetic nervous system. Similarly, after exercising, she should have had a healthy snack: for example,
a glass of milk, chocolate, or hot herbal tea with honey
and a few cookies. This would provide the patient with
enough glucose and complex carbohydrates to prevent
the plasma glucose level from dropping during the night.
Sugary drinks contain sucrose which breaks down
into glucose, but their effect on plasma glucose levels is
short-lived. The effect of complex carbohydrates on the
blood glucose level is much longer lasting because they
first have to be digested and then absorbed through the
intestines. Hence, a good combination is a hot sugary
drink and complex carbohydrate, such as a couple of
cookies or a slice of whole grain bread. The sugary
drinks will have an almost immediate effect on plasma
glucose level that may last a few hours, especially if
consumed hot as this may enhance absorption through
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the gastro-intestinal tract. Ice cream is another option.
Efforts therefore should have been made to emphasize
that in Esther’s case the purpose of eating is to ensure a
good night’s sleep and should be taken “for medicinal
purposes” regardless of whether or not Esther feels
hungry.
Hypoglycemia could be confirmed by assaying the
blood glucose level. The very early nocturnal awakening and ensuing episode could have easily been avoided
had Esther eaten or had a hot sugary drink with a few
cookies or some of the cheesecake her son-in-law bought
earlier that day. As a similar episode happened earlier
that week, it should not have been too difficult to convince Esther of the need to eat and drink before going to
bed. It also would have been very useful to measure her
blood glucose level and share the results with her physician to ensure she is getting the right medication, in the
right dose for her diabetes. Patients treated for diabetes
are more likely to develop hypoglycemia.

a result she had to increase the volume to such an extent
that it woke up the rest of the household.

Physical exertion and showering before going to bed. During
physical exertion, the liver and muscles break down their
glycogen stores to produce glucose which is needed to
meet the energy needs of the exercising muscles. When
exercise stops, the liver and muscles extract glucose from
the blood stream to replenish their glycogen stores (Oda
& Shirakawa, 2014). This may occur over a period of a
few hours and may lead to hypoglycemia.
Strenuous exercise increases body temperature which
also may interrupt sleep. Esther exercised for over an
hour and then proceeded to shower before going to bed.
Depending upon the temperature of the water and duration of the shower her body temperature could have been
kept elevated. Having Esther exercise earlier in the day
may also increase her appetite and desire to eat dinner.

Esther turned on the TV. As Esther did not have her hearing aids, she was unable to hear the TV without increasing the volume to such an extent that it woke up Miranda
and Donald then subsequently Mary Lee.

Could it have been avoided? This episode could have
been avoided had Esther exercised and showered earlier
in the day.
Esther sleeps in a windowless room: A converted den. There
are no windows in Esther’s room, as such, she is not getting any visual cues about the time of the day or night to
adjust her circadian rhythm. When she wakes up, she
has no idea what time it is and whether or not she should
stay in bed and be quiet while her daughter, son-in-law
and granddaughter are still sleepy.

Could it have been avoided? Given that hearing is such
an important element of communication with other people
and that hearing aids are so important to a person sharing
accommodation with others, they should be easily accessible, even in the dark, especially if the person lives in a windowless room, as is the case with Esther. Hearing aids or
headphones should be kept in an illuminated easily accessible container or tray. Similarly, sound from the TV could
be channeled straight to the patient’s ears through earplugs
or headphones. These are easier to use than hearing aids
which need to be inserted through the external auditory
meatus: a particularly difficult task in a person who has just
woken up and may have apraxia as part of the underlying
neurocognitive disorder. A small night light bulb with red
wavelengths could be utilized for visibility without hindering sleep (Brainard et al., 2015; Schmerler, 2015).

Could it have been avoided? The TV could have been
connected electronically to her hearing aids or headphones. This would have allowed her to increase the
volume as high as needed without anyone else being
even aware that the TV is switched on.
If possible, it may have been better to have Esther’s
room in a more remote part of the house where any noise
generated by Esther would not be easily transmitted to
the other bedrooms. Sound proofing would be another
option, albeit an expensive one.
Still another option would have been not to have a
TV in Esther’s bedroom, especially as the light rays
emitted from the TV may interfere with the release of
melatonin from the pineal body in the brain and this per
se, may interfere with the circadian rhythm.

Could it have been avoided? A large well-lit, visible
wall clock or the time projected on the wall immediately
across her bed would have reminded Esther of the time
of the day, would have helped her readjust her circadian
rhythm, and would have encouraged her either to stay
in bed or to be quiet so as not to wake up the rest of the
household.

Stress, depression, and insomnia. Stress and Depression
oftentimes follows the death of a loved one and major
life changes. Given that within the past year, Esther not
only lost her husband but also moved out of her home
into her daughter’s home, Esther could have been experiencing undiagnosed stress and/or depression. Depression interferes with sleep: patients tend to wake up early
in the morning and have a difficult time falling back to
sleep. Early morning awakening is indeed one of the
common manifestations of depression. The stress of
these major life changes could have increased Esther’s
cortisol level, which also contributes to insomnia (Botts,
2010; Dumbell, Matveeva, & Oster, 2016; Spencer,
Chun, Hartsock, & Woodruff, 2017).

Esther dropped her hearing aids and could not retrieve
them. This prevented Esther from hearing the TV and as

Could it have been avoided? It is important to ascertain
whether Esther is depressed. Screening for depression is
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recommended in all older patients, especially those with
mild cognitive impairment. The successful management
of depression is often associated with an improvement
of cognitive functions. A number of screening questionnaires are available.
It is also important to detect suicidal ideation, as the
potential for suicide is high in older people, especially
men, particularly those who live on their own. In Esther’s
case, it is therefore relevant to evaluate her for depression and suicidal ideation. Depression and suicidal ideation in patients with impaired cognitive functions are
discussed in subsequent case studies.

Case Discussion: Scope of the
Problem
Chronic insomnia is defined as difficulties falling asleep
or remaining asleep occurring 3 or more times a week
for 1 or more month (Winkleman, 2015; Diagnostic and
Statistical Manual of Mental Disorders [5th ed.; DSM5]; American Psychiatric Association, 2013). It affects
about one third of the adult population (Winkleman,
2015). About 50% of patients with chronic insomnia
have underlying psychiatric diseases including depression, suicidal ideation, anxiety, impaired cognitive functions, and dementia (Winkleman, 2015). Sleep
complaints are associated with an increased mortality of
common diseases such as ischemic heart diseases, cerebro-vascular accidents and neoplastic lesions
(Gooneratne et al., 2006). Not diagnosing or misdiagnosing the cause of insomnia may have serious nefarious outcomes such as when sleep apnea is missed and
the patient prescribed a hypnotic or a sedative
(Trevorrow, 2010). The incidence of insomnia is higher
in older than younger adults and is associated with poor
health and cognitive impairment (Ancoli-Israel, 2009;
Arbus & Cochen, 2010).

Diagnostic Criteria of Insomnia (DSM-5)
Insomnia is defined as a dissatisfaction with the quantity
or quality of sleep due to difficulties initiating sleep
(sleep-onset or initial insomnia), maintaining sleep
(sleep maintenance or middle insomnia), or early morning awakening with inability to return to sleep (late
insomnia), occurring at least 3 times a week for at least
1 month, despite adequate opportunities to sleep and
provided it is not due to another medical or mental disease, the effects of medication or substance abuse,
including alcohol and is not due to another sleep-wake
disorder (DSM-5). Patients with nonrestorative sleep
complain of a poor sleep quality and of not feeling rested
or refreshed on waking up: They still feel tired.
Apart from nighttime sleep difficulties, insomnia is
often associated with worsening cognitive impairment,
especially difficulties with attention, concentration,
memory, and performance of simple daily tasks. Patients
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are also often irritable, anxious, depressed, and may
exhibit mood lability.

Causes of Insomnia
The causes of insomnia can be classified into three
groups: extrinsic causes, intrinsic causes, and those
related to the individual’s lifestyle.
Extrinsic causes of insomnia include change of bed/
bedroom, uncomfortable bed, noise, excessive lighting,
too low or too high an environmental temperature, and
excessive humidity or dryness. A number of medications
also may induce insomnia including selective serotonin
reuptake inhibitors, theophylline, thyroid hormone,
diuretics, beta-blockers, antiarrhythmics, clonidine,
sympathomimetic stimulants, corticosteroids, and medications containing caffeine. Over-the-counter medications also may predispose to insomnia including nicotine
replacement, energy boosters, and other preparations
containing alcohol or caffeine.
Intrinsic causes include a number of diseases which
may interfere with the quantity and quality of sleep
including restless leg syndrome, sleep apnea, gastroesophageal reflux disorders (giving rise to heartburn),
chronic obstructive airways disease (dyspnea), nocturnal asthma (dyspnea), congestive heart failure (dyspnea,
orthopnea, paroxysmal nocturnal dyspnea, nocturnal
polyuria), coronary artery disease (chest pain), arrhythmias (palpitations), diabetes mellitus (polyuria, peripheral neuropathies, peripheral vascular disease),
inflammatory conditions (pain), arthropathies (pain),
respiratory tract infections (cough, dyspnea), urinary
tract infections (dysuria and frequency), any infection
(pain), renal calculi (pain), and neoplasia (pain). Obesity
also predisposes to insomnia. A number of psychiatric
disorders also may induce insomnia.
Several lifestyle habits also may induce insomnia
including having naps throughout the day, consuming
heavy meals or undertaking strenuous physical exercises shortly before going to bed, excessive alcohol or
caffeine intake before going to bed and mental stress.
Other habits that may detrimentally affect the quantity/
quality of sleep include watching TV, using a laptop
computer, or other electronic devices shortly before
going to bed, or while in bed. These may interfere with
melatonin production and the circadian rhythm. If it is
necessary to use these technologies before bedtime, it is
recommended to use the night shift capabilities which
will diminish the blue light and display the more yellow–orange end of the spectrum (Gronli et al., 2016).
In many instances it is not one factor, but rather a
combination of factors that lead to insomnia: Each factor on its own may not be sufficient to induce insomnia,
but the combination of factors leads to insomnia. It is
therefore important to identify these factors and address
them while managing insomnia. As much as possible
hypnotics should be prescribed only after identifying
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and addressing the cause(s) of the insomnia (Arbus &
Cochen, 2010).

Assessing the Severity and Impact of
Insomnia
Given that assessment of sleep quality and quantity is
such a subjective individual issue, a number of questionnaires are available to objectively assess sleep quality and
quantity (Trevorrow, 2010). A good sleep history from the
patient and bedroom partner, if available, is the first step
in assessing the type and severity of the insomnia taking
into account the various extrinsic factors that may lead to
insomnia. Enquiries should also be made about the
patient’s lifestyle habits that may affect sleep. A thorough
clinical examination is then recommended to identify the
cause(s) of the insomnia. Depending on the findings, a
few laboratory tests and imaging studies may be required.
A number of procedures can be used to assess sleep
quality and quantity including electroencephalograms
(EEGs), polysomnography, audio and video recordings,
measurement of various physiological parameters such
as pulse rate, respiratory rate, eye movement, arousal
thresholds, and a number of other parameters. Sleep
laboratories are also widely available, although it should
be pointed out that only a small number of patients will
require such studies.
A number of smartphone apps, devices, and gadgets
are becoming available to track sleep pattern and offer
targeted advice that may help achieve a better sleep pattern. Some of these devices also provide cranial stimulation. Unfortunately, the background research on most of
these is limited and their long-term efficacy and safety
are not known.

Management of Insomnia
Although managing insomnia, all three groups of factors
(extrinsic, intrinsic, and lifestyle habits) need to be
addressed to tailor the management strategy to the individual circumstances of the particular patient and maximize the impact of the management strategy. Although
managing insomnia nonpharmacological means should
be tried before prescribing hypnotics. Regardless of the
cause(s) of insomnia, good sleep hygiene promotes
restorative, good quality, and good quantity sleep.
A number of nonpharmacologic measures are available to manage insomnia. Their success largely depends
on the cooperation of the patient, her motivation and
willingness to pursue these lines of management. Sleep
specialists trained in behavioral medicine may be able to
help patients with insomnia replace lifestyle habits
responsible for their insomnia with good habits that
enhance the quality and quantity of sleep and its restorative functions. The goal of relaxation techniques is to
train the patient to relax and free herself of mental
impediments to sleep.

The main goal of sleep restriction to manage insomnia is to increase the patient’s sleep drive by reducing
the time in bed (but no less than 5 hr per 24 hr) and
inducing a sleep debt. The patient is expected to respond
by sleeping better during the hours she is allowed to
sleep, thus normalizing her circadian rhythm (Phillips,
Klerman, & Butler, 2017). Once the patient responds
favorably, the amount of time spent in bed is gradually
increased.
The main goal of cognitive behavioral therapy (CBT)
is to restructure the patient’s dysfunctional behaviors
and/or beliefs that perpetuate insomnia. As a result,
sleep latency is shortened, frequency and duration of
nocturnal awakenings are reduced and total sleep time is
lengthened (Cervena et al., 2004). The main limitations
of CBT include the number of sessions required to
achieve good results, the relatively small number of
therapists available and the low patient adherence. Webbased CBT is available and may be helpful.

Sleep Hygiene: Measures to Improve Quality
and Quantity of Sleep
Sleep quality and quantity may be improved by going to
bed at about the same time every day, including weekends. If the individual cannot sleep within 20 to 30 min,
she should not stay in bed. She should get out of bed, get
engaged in some relaxing activity and then return to bed
when she feels tired. Watching TV may be counterproductive, especially if watched in bed and if the program
watched is violent, scary, or needs the individual to concentrate on the show such as watching mystery movies.
Ideally, the material watched should be light-hearted
and relaxing.
Physical exercise is recommended, but not within 2
hr of bedtime. Vigorous physical exercise is associated
with an increased production of catecholamines and
stimulation of the sympathetic nervous system which
interfere with sleep. A hot sweet drink, preferably with
honey and accompanied by one or two cookies, about 30
min before going to bed will ensure the blood glucose
levels do not drop while the patient is asleep. A warm
bath before going to bed will help relax the patient.
The bedroom should be dark or dimly lit, not noisy
and be at a comfortable temperature and degree of
humidity. The mattress should be firm, the bedsheets
clean with no wrinkles and no foreign bodies such as
breadcrumbs, food particles, or other material. Pillows
should be comfortable.

Sleep Hygiene: Measures to Avoid to Improve
Quality and Quantity of Sleep
Mentally demanding, irritating activities should be avoided
for at least an hour before going to bed. The following
should be avoided within 2 hr of going to bed: naps,
vigorous physical exercise, tobacco use, heavy meals

6
especially spicy food which may induce heartburn, alcoholic drinks, high fluid intake (the induced polyuria may
interfere with sleep quality and quantity), and caffeine
containing drinks and food, such as dark chocolate.

Nonprescription, Over-the-Counter,
Pharmacologic Management of Insomnia
The primary active ingredient of most nonprescription
sleeping tablets is an antihistamine compound such as
diphenhydramine or doxylamine. Antihistaminics are
also acetylcholine antagonists. Per se they are not
hypnotics, but, given their sedating effect, they induce
drowsiness and thus help the person initiate and
maintain sleep. Short-term adverse effects include dizziness, impaired coordination, nausea, headaches,
constipation, dysuria, urinary retention, palpitations,
tachycardia, thickened bronchial secretions, diaphoresis, and blurred vision. Their administration also may
induce cognitive impairment and toxic psychosis,
especially in older people. They also may induce
unsteadiness and increase the risk of falls. This can be
quite problematic in older patients with dementia especially as the half-life of these medications tends to be
prolonged in older people. Alcohol intake also potentiates their effect. Although these medications have been
available for a very long time, their long-term safety is
not known.

Dietary Supplements
Dietary supplements do not come under the regulation
of the Food and Drug Administration (FDA). As such,
therefore, they are rigorously tested for neither safety
nor effectiveness. Similarly, their quality and label accuracy are not verified by the FDA. Furthermore, although
touted as “natural” some may contain other active biologic ingredients that may not be mentioned on the
package or label, but nevertheless may interact with
other medications. It is therefore relevant to enquire
about any “dietary supplement” the patient may be taking on a regular basis and identify any possible interaction with the patient’s other medications.
Valerian and chamomile are readily available and
often touted as sleeping aids. Valerian root extract, however, contains more than 100 specifically identified substances (Harvard Medical School Special Health Report,
2013). Our understanding of the mode of action of these
compounds is still limited.

Melatonin
Melatonin facilitates sleep initiation and improves sleep
quality without altering sleep architecture (Zhdanova,
2005). The effects of melatonin are mediated through
specific melatonin receptors. The response to melatonin
in older people, however, is often reduced because of the
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often age-related reduced functional potency of melatonin receptors (Zhdanova, 2005).
Melatonin is available over the counter and often
used to induce sleep. A review of the available literature
by the Agency for Health care Research and Quality
concluded that melatonin reduced sleep latency to a
greater extent in people with delayed sleep phase syndrome, suggesting that it exerts its effects by resetting
the circadian rhythm rather than acting as a hypnotic
(Buscemi et al., 2004). Melatonin also may be effective
at alleviating the effect of symptoms of jet lag (Vosko,
Coldwell, & Avidan, 2010). The administration of exogenous melatonin is safe in the short term (Buscemi et al.,
2004).
Melatonin is synthesized from tryptophan in the
pineal body, located behind the third ventricle in the
brain. Approximately 90% of melatonin is cleared in a
single passage through the liver. A small proportion is
excreted unchanged in the urine. Long-term effects and
safety of melatonin are not known.

Hypnotics
A number of hypnotics are available to induce sleep.
Although they should be used in the lowest dose and for
the shortest period, to maintain their efficacy and limit
the adverse effects, many patients are on hypnotics for
long periods of time. Four main classes of hypnotics are
available: benzodiazepines, nonbenzodiazepines, antidepressants and melatonin receptor agonist.
Benzodiazepines act by enhancing the activity of the
neurotransmitter Gamma Aminobutyric Acid (GABA).
The profile of various benzodiazepines is dependent on
their half-lives and how quickly and for how long their
action lasts. Their main drawback is that they alter sleep
architecture (Borbely et al., 1985; Wagner & Wagner,
2000). The sleep they induce is therefore not as restorative as natural sleep. Their main adverse effects include
psychomotor and memory impairment, next-day
impaired mental alertness, sedation, drowsiness, and
unsteadiness that may increase the risk of falls. Other
side effects include exacerbation of depression and suicidal ideation, aggressive behavior, amnesia, and hallucinations. Many patients develop tolerance and need higher
doses. Abruptly stopping their administration often leads
to rebound insomnia with an increased risk of restlessness, irritability, and rarely convulsions. Benzodiazepines
are best suited for the short-term treatment of insomnia.
Available benzodiazepines have a wide range of halflives: triazolam (1.5 to 5.5 hr), temazepam (8.8 hr),
alprazolam (12 to 16 hr), lorazepam (14 hr), estazolam
(10 to 24 hr), clonazepam (20 to 50 hr), diazepam (30 to
50 hr), and flurazepam (40 to 100 hr).
Nonbenzodiazepines are at least as effective as benzodiazepines at inducing sleep and improving subjective
sleep quality (Uchimura et al., 2006). Their main advantages include their relatively short half-life and that they
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induce less psychomotor and memory impairment than
benzodiazepines and antidepressants (Schneider, 2002).
They, nevertheless alter the sleep architecture, especially in older patients, albeit to a lesser extent than benzodiazepines (Chinoy, Frey, Kaslovsky, Meyer, &
Wright, 2014). Their main adverse effects include nausea, headaches, drowsiness, dizziness, repeated falls,
nightmares, disorientation, agitation, and somnambulism, including nocturnal eating, walking, and even
driving. Dependence, rebound insomnia and withdrawal
symptoms occur less frequently than with benzodiazepines (Wagner & Wagner, 2000). Available nonbenzodiazepines used for insomnia have shorter half-life:
Zaleplon (1 hr), zolpidem (2.5 to 3.1 hr), and eszopiclone (6 hr). Extended release preparations are available
but are associated with changes in sleep architecture and
impaired physical performance during nighttime awakening and the following day and therefore may impact
nefariously on the patient’s safety (Kleykamp, Griffiths,
McCann, Smith, & Mintzer, 2012).
A number of antidepressants are also used for the
management of patients with insomnia, including the
following: Selective Serotonin Reuptake Inhibitors
(citalopram, fluoxetine, fluvoxamine, paroxetine, and
sertraline), Serotonin and Norepinephrine Reuptake
Inhibitor (venlafaxine), Serotonin modulator (trazodone), tetracyclic (mirtazapine), and tricyclics (amitryptiline, doxepin, nortryptiline, and trimipramine). Main
adverse effects include dry mouth, dizziness, daytime,
and drowsiness. Ramelton is a melatonin receptor agonist. Its main adverse effect is that it may exacerbate
depression.

Sleep Structure/Architecture and Cycles
Nocturnal sleep occurs in cycles. It has two distinct
components: Quiet sleep and Rapid Eye Movement
(REM) sleep. Dreams occur during the latter component. Quiet sleep is also known as non-REM sleep and
has three stages.
The first stage: “Quiet or non-REM sleep” represents
the transition between wakefulness to light sleep. During
this stage, the eyes close and the brain, deprived of
visual input, slows down. At the beginning of this stage,
brain waves on the EEG are in the “alpha-wave pattern,”
a rhythmic pattern of about 10 cycles per second. As
Stage 1 progresses brain waves on the EEG slow down
to 4 to 7 per second: “theta wave pattern.” Thinking
slows down as well as the heart rate, breathing rate, and
most physiological activities. Body temperature starts to
fall. Muscles relax but movement may still occur and the
person may change positions looking for a most comfortable position. Eyes move slowly. The person gradually loses spatial orientation, but is easily jarred awake.
Stage 1 of non-REM sleep is often referred to as “an
idling brain in a movable body” and usually lasts about
5 min.

7
During the second stage of non-REM sleep the eyes
are closed, not moving, the heart rate and respiratory
rate slow down further, EEG exhibits large slow waves
intermingling with bursts of activity known as sleep
spindles. Body temperature decreases. The brain disconnects itself from outside sensory input and begins the
process of memory consolidation. On the EEG
K-complexes are evident: They represent a sort of vigilance system that, if necessary, allows the person to
wake up. Stage 2 lasts 10 to 25 min. If the person is not
woken up, she proceeds to Stage 3.
During the third stage, also known as deep sleep,
large slow waves: “delta waves” become prominent on
the EEG. This stage is also sometimes referred to as the
“Slow Wave Sleep.” The blood pressure drops, breathing and heart rates slow down further to about one third
below the level during wakefulness. The brain is less
responsive to external stimuli and it is difficult to wake
up the person sleeping in this stage. During this stage,
the pituitary gland releases growth hormone which stimulates tissue growth and allows the body to renew and
repair itself. The immune system is also stimulated. This
stage lasts about 30 min in young adults, but gets progressively shorter as individuals age. When subjects are
deprived of this stage, they wake up feeling less
refreshed and when offered the opportunity of sleeping
again, tend to rapidly descend to the third stage, thus
spending more time in this stage and less time in Stages
1 and 2.
REM sleep is characterized by dreaming and has
been described as an “active brain in a paralyzed body”:
the eyes, while closed, move rapidly, body temperature
rises, blood pressure increases, heart, and breathing
rates increase. The sympathetic nervous system is activated and launches the fight-or-flight response, but the
body is essentially paralyzed except for occasional
twitches and the REMs. During this stage, the brain processes information received during the day. REM-sleep
facilitates learning and enhances memory. The initial
REM-sleep stage lasts only a few minutes, but as the
night progresses this stage tends to become longer. In a
way, the body having physically repaired and renewed
itself during the third stage, now addresses the person’s
mental and cognitive functions. When persons who have
been deprived of REM sleep are allowed to sleep uninterrupted, they rapidly go to the REM-sleep stage. This
is referred to as “REM rebound.”
Non-REM sleep alternates with REM sleep, each
cycle lasts 60 to 90 min. On average people go through
three to five cycles a night. As the night progresses, the
time spent in REM and Stage 1 sleep gets longer, while
Stage 3 gets shorter and may be altogether absent.
As individuals grow older, sleep latency, which is the
time needed to transition from wakefulness to Stage 1
non-REM sleep tends to be prolonged, while the total
duration of nocturnal sleep tends to decreases. Similarly,
time spent in Stage 2 increases while the time spent in
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Stage 3 and REM-sleep decreases. Sleep is also more
fragmented and daytime naps are more frequent than in
younger adults (Arbus & Cochen, 2010).
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This case report has not been previously published.
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Summary/Teaching Points
•• Nocturnal hypoglycemia is a cause of sleep disturbances: middle or late insomnia and is often
precipitated by lack of food or physical exertion
before going to bed.
•• Causes of insomnia can be classified into three
groups due to extrinsic factors, intrinsic factors,
and lifestyle habits. All three groups should be
addressed as often the etiology of insomnia, especially in older patients with dementia is
multifactorial.
•• Sleep hygiene plays an important role in maximizing the quality and quantity of sleep. Patients
and caregivers should be made aware of the various measures to undertake and those that need to
be avoided. Sleep hygiene should be prescribed
to patients with insomnia, in conjunctions with
other measures taken.
•• A number of dietary supplements and sleep aids
are available. They are not regulated by the FDA.
There is a paucity of good research on their use to
facilitate and maintain sleep.
•• A number of nonprescription medications are
available. The active ingredient in most is an
antihistamine compound such as diphenhydramine. They are not hypnotics, but induce
drowsiness which may lead to unsteadiness and
falls. They tend to have long half-lives and
therefore physical and mental performance the
following day(s) may be impaired, particularly
in older patients.
•• Melatonin is available over-the-counter in the
United States. It is secreted by the pineal body
and helps maintain the circadian rhythm. It facilitates sleep initiation and improves sleep quality
without altering sleep architecture.
•• Prescription hypnotics include benzodiazepines,
nonbenzodiazepine, antidepressants and a melatonin receptor agonist. The former three alter
sleep architecture to various degrees and therefore may interfere with the quality of the sleep
they induce.
•• Strategies to reduce the impact of watching TV
on other cohabitants include using a headset connected directly or electronically to the TV, using a
room as far away as possible from other bedrooms and sound proofing the TV room.
•• Circadian rhythm disorders can be helped by a
large wall clock visible from a distance, a 24-hr
clock, exposure to bright lights early afternoon to
reset the melatonin diurnal rhythm and administration of melatonin in late evening.
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